Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on May 14, 2025
US FDA Orphan Drug Rare Disease Market Clinical Trials Drug Sales Insight 2030
GlobeNewswire
·
May 14, 2025
Delhi, May 14, 2025 (GLOBE NEWSWIRE) -- US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight 2030 Report Offering and Highlights: US Orphan Designated Drugs Market Opportunity: > US$ 190 Billion By 2030 …
Global Robotic Biopsy Devices Market Set to Surge, Projected to Reach USD 144.2 Million by 2035 | FMI
EIN Presswire
·
May 14, 2025
Explore emerging trends, innovations, and market forecasts driving the growth of robotic biopsy devices from 2025 to 2035 NEWARK, DE, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- The global robotic biopsy devices market is poised for transformative …
Virtual Companion Care Market Set to Surpass USD 14.4 Million by 2033, witness a CAGR of 6.2% | FMI
EIN Presswire
·
May 14, 2025
Explore key trends, drivers, and forecasts shaping the Virtual Companion Care Market from 2023 to 2033 NEWARK, DE, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- The virtual companion care market is expected to secure a CAGR of 6.2% during the …
Global Osteotomy Plates Market to Surpass USD 698.5 Million by 2035 Driven by Joint Preservation Surgeries | FMI
EIN Presswire
·
May 14, 2025
Osteotomy Plates Market poised for steady growth through 2035, driven by rising orthopedic procedures and technological advancements NEWARK, DE, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- The global osteotomy plates market is on a trajectory of …
Global Veterinary Orthotics-Prosthetics Market Set to Surge Past USD 140.0 Million by 2035, grow at a CAGR of 6.4% | FMI
EIN Presswire
·
May 14, 2025
Global Veterinary Orthotics and Prosthetics Market to Witness Robust Growth Driven by Advancements in Animal Mobility Solutions (2025–2035) NEWARK, DE, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- The global veterinary orthotics-prosthetics market …
Aptose Selected for Prestigious Oral Presentation of Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2025 EHA Congress
GlobeNewswire
·
May 14, 2025
Aptose is developing TUS+VEN+AZA as a one-of-a-kind safe and mutation agnostic frontline triple drug therapy for newly diagnosed AML Oral presentation at EHA will include updated data at the 40 mg and 80 mg dose levels and longer duration SAN DIEGO and …
Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight
GlobeNewswire
·
May 14, 2025
New York, USA, May 14, 2025 (GLOBE NEWSWIRE) -- Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight The expansion of the preeclampsia diagnostics market is largely fueled by the rising prevalence of preeclampsia …
Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
GlobeNewswire
·
May 14, 2025
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 14 May 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in …
Best Creatine For Men 2025: Top Athlete-Tested Supplements for Muscle Growth, Strength & Recovery
GlobeNewswire
·
May 14, 2025
Glasgow, May 14, 2025 (GLOBE NEWSWIRE) -- Introduction In simple words, creatine is a substance that occurs naturally in our muscle cells. It helps our muscles produce enough energy while we perform intense activities such as heavyweight lifting or a high …
Sevaro Launches Nationwide Stroke Awareness Campaign With Racecars, Storybooks, and Student Heroes
GlobeNewswire
·
May 14, 2025
CHARLOTTE, N.C., May 14, 2025 (GLOBE NEWSWIRE) -- A stroke happens every 40 seconds in the U.S.—and every minute without treatment can cost a person 1.9 million brain cells. This May, during Stroke Awareness Month Sevaro Health is shifting the narrative— …
The Best Steroids for Cutting, Muscle Growth & Strength for Weight Training - Top Legal Steroid Stacks for Bulking, Fat Loss, Getting Shredded & Ripped - CrazyBulk
GlobeNewswire
·
May 14, 2025
New York City, NY, May 14, 2025 (GLOBE NEWSWIRE) -- For serious bodybuilders and weightlifters, achieving fast muscle growth and that shredded look takes more than just hard work in the gym. The right steroid stack will push past limits, pack on lean …
REPEAT/Media Advisory/OHC - Day of Action at Ontario Legislature to Stop Hospital Closures
GlobeNewswire
·
May 14, 2025
TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- On Wednesday May 14, people from across Ontario will be heading into the Ontario Legislature for a “Day of Action” to ask the Ford government to stop closing their local hospitals and to provide the resources …
Angelini Ventures Invests into $39 Million Series A Extension Round for Therini Bio, a Clinical Stage Company Developing Fibrin-targeting Immunotherapies for Neurodegenerative Diseases
GlobeNewswire
·
May 14, 2025
Angelini Ventures joins top-tier investor syndicate Investment will fund Phase 1b studies evaluating Therini Bio’s lead candidate, THN391, for the treatment of Alzheimer’s Disease (AD) and Diabetic Macular Edema (DME), as well as support development of a …
“Say the ‘S’ word:” Physician-Patient Alliance for Health & Safety Launches CME Sepsis Courses
GlobeNewswire
·
May 14, 2025
Chicago, IL, May 14, 2025 (GLOBE NEWSWIRE) -- “Say the ‘S’ word:” Physician-Patient Alliance for Health …
Kura Oncology and Kyowa Kirin Announce Combination Data for Ziftomenib in Oral Presentation at the 2025 European Hematology Association (EHA) Congress
GlobeNewswire
·
May 14, 2025
– Ziftomenib combined with 7+3 in 1L NPM1-m or KMT2A-r AML patients selected for oral presentation on Thursday, June 12th – – Updated dataset to be presented in oral presentation at EHA2025 Congress – SAN DIEGO and TOKYO, May 14, 2025 (GLOBE NEWSWIRE) -- …
Therini Bio Raises Additional $39M Series A Financing to Advance Clinical Development of Neurodegenerative Disease Pipeline
GlobeNewswire
·
May 14, 2025
- Angelini Ventures and Apollo Health Ventures join existing top-tier investor syndicate - Follows original $36M Series A raise and brings Series A total to $75M - Proceeds are being used to fund Phase 1b Alzheimer’s and DME studies, and bispecific …
Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress
GlobeNewswire
·
May 14, 2025
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that new data on the company’s PK …
Editas Medicine to Present in vivo HSC Delivery, Editing, and Biodistribution Data at the European Hematology Association 2025 Congress in June
GlobeNewswire
·
May 14, 2025
Preclinical studies achieved therapeutically relevant gene editing levels of the HBG1/2 promoter …
Nurix Therapeutics Announces Presentations of Clinical Data at the 30th European Hematology Association Congress and the 18th International Conference on Malignant Lymphoma
GlobeNewswire
·
May 14, 2025
SAN FRANCISCO, May 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that …
Beam Therapeutics to Highlight New Data from BEAM-101 Program in Sickle Cell Disease at European Hematology Association (EHA) 2025 Congress
GlobeNewswire
·
May 14, 2025
Presentation to Include Updated Data from 17 Sickle Cell Disease Patients in the Ongoing BEACON Phase 1/2 Clinical Trial Evaluating Safety and Efficacy of BEAM-101 Beam to Host Investor Webcast on Friday, June 13, 2025, at 4:00 p.m. ET CAMBRIDGE, Mass., …